Study: PC 20

PC 20
Kidney Studies

• To determine how the investigational drug, an iron salt for the maintenance of hemoglobin levels, is absorbed, broken down, and removed from the body in volunteers with kidney impairment on hemodialysis.
• Information regarding safety and side effects that may occur will also be collected.
• This study is for research purposes only and is not intended to treat your kidney disease.

Method of Administration:
Multiple doses of study medication given through hemodialysate solution and intravenously (IV)
Thomas Marbury, MD
Key Requirements to qualify for this study:

• 18 to 80 years old
• Currently receiving hemodialysis


4 in-center dialysis sessions over an approximate 2 week period and 1 follow-up visit

5055 South Orange Avenue, Orlando, FL 32809

Qualified participants will receive up to $950 for time and travel

Whom to Contact:
Recruitment Department: 407-240-7876

Apply Now